Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.

Dario Arnaldi Fabrizio De CarliFrancesco FamàAndrea BrugnoloNicola GirtlerAgnese PiccoMatteo PardiniJennifer AccardoLuca ProiettiFederico MassaMatteo BaucknehtSilvia MorbelliGianmario SambucetiFlavio Nobili

Published in: Movement disorders : official journal of the Movement Disorder Society (2017)

Resting EEG and 123 I-FP-CIT-SPECT are good predictors of future cognitive worsening, in de novo drug-naive PD patients. Wherever available, these biomarkers could add valuable prognostic information to classification into different clinical phenotypes. © 2017 International Parkinson and Movement Disorder Society.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
machine learning
peritoneal dialysis
functional connectivity
heart rate
emergency department
deep learning
heart rate variability
resting state